AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc. is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The company develops software platforms and programmable infrastructure to facilitate the tokenization of real-world assets ("RWA") and the deployment of Embodied Artificial Intelligence ("EAI") in commercial environments. Its purpose is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems. In September 2025, the company closed a $41 million PIPE financing. In November 2025, it rebranded from Qualigen Therapeutics to AIxCrypto Holdings, Inc. Following this, the company initially operated across three business lines: the BesTrade DeAI Agent platform, the C10 digital asset treasury and portfolio management tools, and the RWA Embodied AI (EAI) ecosystem. In February 2026, the company's board decided to concentrate on the RWA + Embodied AI (EAI) ecosystem. As a result, the company has discontinued development of the BesTrade platform and the C10 portfolio management tools. These products were early-stage proofs of concept and did not align with the company's revised focus on enterprise and institutional infrastructure regarding scale, regulatory profile, or margin characteristics. The company does not anticipate material impairment charges beyond what has been previously disclosed from this discontinuation. Separately, the company continues to evaluate strategic options for its therapeutics programs, previously under the Qualigen brand. These options include proceeding with the existing QN-302 trial, licensing the asset, or an outright sale.